A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With Dercum's Disease Lipomas
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This Phase 2 study will be an open-label and randomized study to assess the efficacy and
safety of CBL-514 in participants with Dercum's Disease lipomas.